USAResearch and clinical trials
Adding cholic acid to cholesterol studied in 8 patients with Smith-Lemli-Opitz syndrome
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In SLOS, the body cannot make enough cholesterol; treatment is cholesterol supplementation. In the USA, the records of eight patients taking cholic acid along with cholesterol were reviewed. In most patients, blood cholesterol rose and growth improved. Families reported positive changes in behavior and communication. Serious side effects were uncommon.
What does it mean for patients and families?
The study was supported by a drug company and is a small series without a comparison group. Larger studies are needed; treatment decisions are made with the doctor.
Source
Scientific paper: Use of cholic acid in Smith-Lemli-Opitz syndrome (SLOS): real-world patient outcomes. Orphanet Journal of Rare Diseases, 2025. DOI: 10.1186/s13023-025-03914-x · PubMed 40722188
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Smith-Lemli-Opitz syndrome (SLOS)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.